Fetal Heart Rate Monitoring Device Market

Executive Summary

Fetal Heart Rate Monitoring Device Market was valued at US $3.99 billion in 2021 and is projected to grow at 7.79% CAGR over the forecast period to reach US $6.25 billion by 2027. Fetal Heart Rate Monitoring Device Market represented US $0.56 billion opportunity over 2019-2021 and estimated to create US $2.27 billion opportunity in 2027 over 2021.

Fetal Heart Rate Monitoring Device from Consainsights analyses the Fetal Heart Rate Monitoring Device Market in the Life Sciences industry over the forecast period to 2027.

Fetal Heart Rate Monitoring Device research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Fetal Heart Rate Monitoring Device segmentation includes Product Class, Technology Type, Portablity of Device and Geography.

Based on the Product Class, the Fetal Heart Rate Monitoring Device analysis covers Internal Heart Rate Monitoring Device, External Heart Rate Monitoring Device.

In Product Class segment, Internal Heart Rate Monitoring Device segment has highest cagr growth of 6.89%.

Based on the Technology Type, the Fetal Heart Rate Monitoring Device analysis covers Doppler Ultrasound Device, Electronic Fetal Monitoring Device.

In Technology Type segment, Doppler Ultrasound Device segment has highest cagr growth of 6.89%.

Based on the Portablity of Device, the Fetal Heart Rate Monitoring Device analysis covers Portable, Non-portable.

In Portablity of Device segment, Portable segment has highest cagr growth of 6.89%.

Based on the region, the Fetal Heart Rate Monitoring Device analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Philips Healthcare, GE Healthcare, Siemens Healthineers, Cooper Surgicals Inc., MedGyn Products Inc., Edan Instruments, Sunray Medical Appratus Co., Bionet America, Trismed Co, Ltd, Mindray Medicals, Fujifilm Sonosite Inc., Natus Medical Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product Class

Introduction

In 2021, Internal Heart Rate Monitoring Device segment has the highest revenue of US $2.82 billion and is expected to grow at CAGR of 6.89% by 2027 Internal Heart Rate Monitoring Device segment has highest cagr growth of 6.89%.

Internal Heart Rate Monitoring Device

Internal Heart Rate Monitoring Device segment was valued at US $2.43 billion in 2019 and is projected to grow at 6.89% CAGR over the forecast period to reach US $4.43 billion by 2027. Internal Heart Rate Monitoring Device segment represented US $0.39 billion opportunity over 2019-2021 and estimated to create US $1.61 billion opportunity in 2027 over 2021.

External Heart Rate Monitoring Device

External Heart Rate Monitoring Device segment was valued at US $1.00 billion in 2019 and is projected to grow at 6.89% CAGR over the forecast period to reach US $1.82 billion by 2027. External Heart Rate Monitoring Device segment represented US $0.16 billion opportunity over 2019-2021 and estimated to create US $0.66 billion opportunity in 2027 over 2021.

Technology Type

Introduction

In 2021, Doppler Ultrasound Device segment has the highest revenue of US $2.96 billion and is expected to grow at CAGR of 6.89% by 2027 Doppler Ultrasound Device segment has highest cagr growth of 6.89%.

Doppler Ultrasound Device

Doppler Ultrasound Device segment was valued at US $2.55 billion in 2019 and is projected to grow at 6.89% CAGR over the forecast period to reach US $4.65 billion by 2027. Doppler Ultrasound Device segment represented US $0.41 billion opportunity over 2019-2021 and estimated to create US $1.68 billion opportunity in 2027 over 2021.

Electronic Fetal Monitoring Device

Electronic Fetal Monitoring Device segment was valued at US $0.88 billion in 2019 and is projected to grow at 6.89% CAGR over the forecast period to reach US $1.61 billion by 2027. Electronic Fetal Monitoring Device segment represented US $0.14 billion opportunity over 2019-2021 and estimated to create US $0.58 billion opportunity in 2027 over 2021.

Portablity of Device

Introduction

In 2021, Portable segment has the highest revenue of US $2.59 billion and is expected to grow at CAGR of 6.89% by 2027 Portable segment has highest cagr growth of 6.89%.

Portable

Portable segment was valued at US $2.23 billion in 2019 and is projected to grow at 6.89% CAGR over the forecast period to reach US $4.06 billion by 2027. Portable segment represented US $0.36 billion opportunity over 2019-2021 and estimated to create US $1.47 billion opportunity in 2027 over 2021.

Non-portable

Non-portable segment was valued at US $1.20 billion in 2019 and is projected to grow at 6.89% CAGR over the forecast period to reach US $2.19 billion by 2027. Non-portable segment represented US $0.19 billion opportunity over 2019-2021 and estimated to create US $0.79 billion opportunity in 2027 over 2021.